Locations:
Search IconSearch

Cancer

21-CHP-2168758-Hero-Opt2
March 10, 2022/Cancer

ONC201 and Neuroendocrine Tumors: Promising Findings From a Phase II Trial

New findings about the drug’s safety and efficacy from a phase II trial

Liposarcoma biopsy under microscopy zoom in different ranges
March 10, 2022/Cancer/Surgical Oncology

Sarcoma Nestled Between Esophagus, Trachea and Aortic Arch: A Case Study

Preoperative chemotherapy enables successful surgical resection

Mukherjee CQD 654×450
March 8, 2022/Cancer/Blood Cancers

Novel Algorithm Highlights the Burden of Idiopathic Multicentric Castleman Disease

Claims data reveal disorder is often overlooked and undertreated

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dana Angelini, MD
March 2, 2022/Cancer/Blood Cancers

Updated Guidelines for Immune Thrombocytopenic Purpura Focus on Treating Patients Without Bleeding

Management options expand in both inpatient and outpatient settings

3d illustration of a cross-section of a diseased skin with melanoma that enters the bloodstream and lymphatic tract
February 24, 2022/Cancer/Surgical Oncology

New Model Based on CD8 T Cells May Distinguish ICI Responders from Non-Responders in Melanoma

Study finds high levels of a CD8 T-cell subpopulation to be predictive of ICI resistance

Pediatric cancer survivor
February 15, 2022/Cancer

Let’s Talk About Childhood Cancer Survivorship (Podcast)

Seth Rotz, MD, joins the Cancer Advances podcast to share insights

Cross section of human breast cross section. 3d illustration
February 10, 2022/Cancer/Surgical Oncology

Bioimpedance Spectroscopy May Be Best Tool for Preventing Breast Cancer-Related Chronic Lymphedema

Low-strength electrical current identifies at-risk patients with greater accuracy than tape measurement

Lab equipment centrifuging blood. Concept image of a blood test.3d rendering.
February 3, 2022/Cancer/Blood Cancers

Newly Identified Risk Factors Help Predict How Aplastic Anemia Can Become Malignant

Study reveals characteristics that may spark the development of myelodysplastic syndrome and acute myeloid leukemia

BackPage 35 of 87Next

Advertisement

Ad